HEMSS (hemihyperesthesia with myelopathy and spinal stenosis) syndrome is a rare neurological disorder characterized by a combination of symptoms such as hemihyperesthesia (decreased sensitivity on one side of the body), myelopathy (spinal cord damage) and spinal stenosis (narrowing of the spinal canal). This disease often leads to severe motor and sensory impairments, which significantly affects the patient's quality of life. The pathogenesis of the syndrome remains poorly understood, but it is known to be associated with various neurological dysfunctions and, in some cases, may occur as a consequence of trauma or degenerative changes in the spine.
History of the disease and interesting historical facts
HEMS syndrome was first described in the medical literature during an exciting period in the late 20th century when neurology was rapidly developing. The first characterization of the condition was presented in 1988, when several case reports were combined to code the syndrome as a separate nosological entity. An important contribution to the study of this syndrome was the work of many neurologists who found that it was not an independent disease, but rather a complex of symptoms arising from various primary diseases. The history of the disease is filled with interesting cases in which the syndrome was misdiagnosed as other neurological disorders, which highlights the complexity of its clinical manifestations and the importance of correct diagnosis.
Epidemiology
Data on the prevalence of HEMS remain limited because the disease is rare and its diagnosis is often difficult. Available data suggest an incidence of approximately 1 case per 100,000 population. The syndrome is most often diagnosed in people aged 40–60 years, but cases can occur in both young and old people. It is important to note that sexual dimorphism in the incidence of the disease has not been established, and studies have not found significant racial differences in the manifestations of the disease.
Genetic predisposition to this disease
Although HEMS syndrome may be associated with various genetic factors, no specific genes have been identified to date that are associated with this disease. Research shows that some mutations in genes responsible for the function of nerve cells and the spinal cord may predispose to the development of this syndrome. In particular, mutations associated with impaired neurotrophic regulation and autoimmune processes are of particular interest to scientists.
Risk factors for the development of this disease
Risk factors for this syndrome can be divided into two main groups: physical and chemical factors. Physical factors include:
- Spinal injuries;
- Spinal deformities;
- Degenerative changes in the intervertebral discs.
Chemical factors include:
- Exposure to heavy metals;
- Toxic substances.
In addition, there is a connection between the syndrome and other neurological diseases, such as multiple sclerosis and various forms of myelitis.
Diagnosis of this disease
Diagnosis of HEMS syndrome includes a number of clinical, laboratory and radiological studies. The main symptoms that the doctor pays attention to are:
- Hemihyperesthesia;
- Weakness in the limbs;
- Coordination disorders.
Laboratory tests may include:
- Complete blood count;
- Clinical tests for autoimmune markers;
- Magnetic resonance imaging (MRI) to visualize the spinal cord.
Other diagnostic tests include electromyography and nerve conduction studies. Differential diagnosis includes ruling out other neurological disorders.
Treatment
Treatment of GEMSS syndrome is complex and may include both conservative and surgical methods. General treatment is aimed at eliminating the underlying cause of the disease and optimizing the functions of the central nervous system. Pharmacological treatment may include:
- Nonsteroidal anti-inflammatory drugs;
- Corticosteroids;
- Psychotropic drugs for the management of depression and anxiety.
Surgical treatment may be required in cases of severe spinal stenosis, where decompression of the spinal canal is necessary. Physical therapy and rehabilitation programs are also helpful and can significantly improve the quality of life of patients.
List of medications used to treat this disease
- Ibuprofen;
- Prednisolone;
- Gabapentin;
- Duloxetine;
- Ketorolac.
Disease monitoring
Control stages of treatment of GEMSS syndrome involve regular examinations by a neurologist to assess the dynamics of the patient's condition, control possible complications and correct treatment. The prognosis of the disease depends on its early diagnosis and adequacy of treatment. Complications may include progression of myelopathy and development of spinal instability in case of neglect of treatment.
Age-related features of the disease
HEMS syndrome may present in different age groups with distinctive features. In younger patients, the main symptoms are acute pain and weakness, while in older people, more pronounced hemihyperesthesia and coordination disorders may be observed. It is important to consider the individual characteristics of each patient when choosing treatment methods.
Questions and Answers
- What is HEMS syndrome? It is a rare neurological disorder characterized by hemihyperesthesia and myelopathy.
- What causes HEMS syndrome? Causes may range from trauma to genetic factors, but the specific etiology remains unclear.
- What are the symptoms of HEMS syndrome? The main symptoms include hemihyperesthesia, motor weakness and impaired reflexes.
- How is HEMS syndrome treated? Treatment includes drug therapy, physical therapy and, in some cases, surgery.
- What is the outlook for recovery from HEMS syndrome? The prognosis depends on early diagnosis and adequate treatment, and many patients can achieve significant improvements.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov advises:
— Undergo regular neurological examinations for early diagnosis.
— Pay attention to physical activity and rehabilitation after treatment.
— Maintain a healthy lifestyle and avoid injuries that may trigger symptoms.
— Work with a psychologist to combat depression if it occurs against the background of illness, as this can significantly improve the overall condition.
